Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalamine and Amitriptyline in IBS-D
NCT02190526Phase 4Withdrawn
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Salcrozine, amitriptyline in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Tehran University of Medical Sciences. Planned start Sep 2014; status: withdrawn.
02
Drugs
Salcrozineamitriptyline
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT02190526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02190526.